Published in
Elsevier, Digestive and Liver Disease, 10(52), p. 1143-1147, 2020
DOI: 10.1016/j.dld.2020.06.034
Links
Tools
Maintenance treatment with fluoropyrimidine plus bevacizumab versus fluoropyrimidine alone after induction chemotherapy for metastatic colorectal cancer: The BEVAMAINT - PRODIGE 71 - (FFCD 1710) phase III study
Journal article published in 2020 by
Sylvain Manfredi,
Anthony Turpin 
,
David Malka,
Emilie Barbier,
Pierre Laurent-Puig,
Aziz Zaanan,
Laeticia Dahan,
Lièvre Astrid,
Phelip Jean-Marc,
Pierre Michel,
Vincent Hautefeuille,
Legoux Jean-Louis,
Lepage Côme,
Tougeron David,
Thomas Aparicio
,
David Malka,
Emilie Barbier,
Pierre Laurent-Puig,
Aziz Zaanan,
Laeticia Dahan,
Lièvre Astrid,
Phelip Jean-Marc,
Pierre Michel,
Vincent Hautefeuille,
Legoux Jean-Louis,
Lepage Côme,
Tougeron David,
Thomas Aparicio
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 